Signal Notes

Editorial signal briefings on Korean equities, sector momentum, and machine-tracked follow-through.

signal EN Uncategorized 2026-08-14

CREX Volume Jumps 5.1x as Q2 Earnings Call Meets Options Expiry

CREX volume surged 5.1x average on Q2 earnings day/options expiry, but a 67.5% EPS miss and 744% debt ratio warrant caution in this unclassified-sector name.

Chain signal:CREX:2026-08-13
자동 생성 콘텐츠 자동 분석으로 생성됐으며 모든 문장을 사람이 사전 검수한 것은 아닙니다.

CREX Volume Jumps 5.1x as Q2 Earnings Call Meets Options Expiry

Trading volume in Creative Realities (CREX) surged to 5.1x its 20-day average on August 13, the exact session in which the company held its Q2 2026 earnings call while options on the stock expired — a rare overlap of a company-specific catalyst and mechanical options-driven flow that puts CREX on the watchlist for traders parsing whether the move reflects genuine repositioning or short-term expiry noise.

The backdrop complicates the read: the quarter itself missed estimates by a wide margin, with EPS landing at -$0.41 against a -$0.2448 consensus, yet the stock's PEG ratio of 0.48 suggests the market may still be pricing in above-average growth relative to its current valuation.

CREX price chart

Key Facts

Stock nameCREX
TickerCREX
MarketNASDAQ
SectorUnclassified
Volume (x average)5.1x
Signal price$3.36

Creative Realities, Inc. designs, deploys, and manages digital signage and in-store retail media network solutions for clients across the U.S. and internationally, reselling hardware from original equipment manufacturers alongside its own software platforms such as ReflectView, Reflect Xperience, and the AdLogic ad-tech management system. The company also operates CPM+, a demand- and supply-side platform, positioning it across both the hardware deployment and advertising-technology layers of the digital signage business.

Recent Analyst Coverage

External analyst opinions (not investment advice): (2026-08-01)

Strong Buy3
Buy6
Hold1
Sell0
Strong Sell0

Peer Companies

FLNT, THRY, SCOR, MCHX, GOAI

Risk Factors

The fundamentals attached to this signal are mixed at best. CREX missed Q2 2026 EPS estimates by 67.5% (-$0.41 actual vs. -$0.2448 expected), and the balance sheet carries a 744% debt ratio alongside a -234.3% return on equity — leverage and profitability metrics that leave little room for execution missteps in a small-cap, unclassified-sector name. The stock's EV/EBITDA of 50.9x is also elevated for a company posting negative returns on equity, meaning any downward revision to growth expectations could hit the valuation disproportionately.

Timing adds another layer of noise: the volume spike coincided with an options expiry date, which can mechanically distort short-term price and volume readings independent of the earnings news itself. Macro conditions are currently calm — the VIX sits at 14.6 and the 10-year Treasury yield has edged up just 0.07 percentage points over the past month to 4.64%, both trending sideways, while the dollar index has drifted 0.8% lower over the same period — but this low-volatility backdrop can mask thin liquidity in less-followed names like CREX, where a shift in risk appetite could produce outsized moves in either direction.

Recent Disclosures

Recent News

Earnings Trend

Fiscal YearRevenueNet Income
2023-$-3M
2024-$-4M
2025-$-8M

Pre-Trade Checklist

Business & competitive edge understood✅ Company profile summarized above
Leading sector⚠️ Not flagged as a leading sector
Good news already priced in?⚠️ Insufficient valuation data to judge
Stop-loss / take-profit set✅ Stop-loss -10% / first take-profit +20% set in advance
Exit plan if wrong✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support

Trade Levels

Signal price$3.36
Stop-loss$3.02 (-10% from signal price)
First take-profit$4.03 (+20% from signal price)
Trailing stop10% from peak
InvalidationClose back below key support ($3.35)

For now, CREX belongs on the watchlist rather than the buy list: the signal price of $3.36 sets the reference point, with a stop-loss at $3.02 defining the downside risk and a first take-profit target at $4.03 marking where the thesis would be validated, after which a 10% trailing stop would look to protect further gains; a close back below $3.35 would undercut the setup entirely and is the level worth watching most closely in the sessions ahead.